2026 NPPES data Hematology & Oncology Physician NPI 1558706069 M.D., PH.D.
Verify on CMS →

DEBORAH DOROSHOW, M.D., PH.D.

Hematology & Oncology Physician in NEW YORK, New York. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.

Federal data — no proprietary rating. PlainDoctor publishes the actual CMS NPPES and Medicare records — NPI registration, specialty, practice location, and prescribing data — without a composite score or editorial opinion on top. Every field traces to a federal source.
Prescribing volume
208
Medicare Part D claims · 36 beneficiaries · Hematology & Oncology Physician avg: 847
Generic prescribing
74%
generic claims · 26% brand-name · higher generic rates reduce patient out-of-pocket costs
Industry payments
$5.2K
8 payments · CMS Open Payments (Sunshine Act)
What the federal data reveals: DEBORAH DOROSHOW, M.D., PH.D. is a Hematology & Oncology Physician ([object Object]) practicing in NEW YORK, New York with a Medicare Part D prescribing footprint of 208 claims across 36 beneficiaries — 26% brand-name prescribing . Industry payments of $5.2K across 8 transactions are disclosed under CMS Open Payments (Sunshine Act).

What stands out: DEBORAH DOROSHOW, M.D., PH.D. filed 208 Medicare Part D claims in 2023 across NEW YORK, New York. Every figure on this page comes straight from federal CMS records, with no proprietary rating applied.

Board certification likely (heuristic — not verified)

DEBORAH DOROSHOW, M.D., PH.D. practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + 1 hospital affiliation — signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).

DEBORAH DOROSHOW, M.D., PH.D. at a glance

Quality data not reported

NPI registry status

Active

Issued 05/10/2013

NPI 1558706069

Primary specialty

Hematology & Oncology Physician

Mid-sized

11,215 US NPIs in this specialty

Medicare Part D claims

208 75% vs specialty avg

2023 prescription claims

Specialty avg: 847

Specialty distribution in New York

How Hematology & Oncology Physician compares to other specialties among New York providers

New York providers

Hematology & Oncology Physician share within New York

1. Hematology & Oncology Physician42%2. Internal medicine21%3. Family medicine17%4. Surgical12%5. Pediatric8%
Hematology & Oncology Physician share within New York

Specialty board-certification context

Estimated specialty board-certified rate — Hematology & Oncology Physician (ABMS / AOA reference)

Quality data not reported
Est. board-certified rate
78%
Hematology & Oncology Physician ABMS/AOA estimate

Est. board-certified rate (Hematology & Oncology Physician) — ABMS / AOA estimate

0%100%78%
Est. board-certified rate (Hematology & Oncology Physician) — ABMS / AOA estimate

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

DEBORAH DOROSHOW, M.D., PH.D. is a Hematology & Oncology Physician provider practicing in NEW YORK, New York, according to the CMS National Plan and Provider Enumeration System (NPPES). Credentials: M.D., PH.D.. NPI: 1558706069. This profile includes practice location, specialty classification, and organizational affiliations from the CMS provider registry. Provider information is self-reported to CMS and updated monthly.

DEBORAH DOROSHOW, M.D., PH.D. appears in the CMS NPPES registry as a Hematology & Oncology Physician provider holding M.D., PH.D. credentials at 10 E 102ND ST, NEW YORK, NY, 10029, with a listed phone of (212) 241-6756. NPI 1558706069 was issued on 05/10/2013. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what DOROSHOW most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.

Medicare Part D records for calendar year 2023 show 208 prescription claims written by this provider, covering 36 Medicare beneficiaries and totaling roughly $383K in drug spend, split 26% brand-name and 74% generic by claim count. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy.

Hematology & Oncology Physician is a mid-sized specialty nationwide, with 11,215 enrolled providers across 54 states and an average of 847 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.

Practice Address

10 E 102ND ST
NEW YORK, NY 10029

Provider Details

NPI 1558706069
Specialty Hematology & Oncology Physician
Credentials M.D., PH.D.
Gender Female
NPI Issued 05/10/2013

Hospital and facility affiliations

Facilities where DEBORAH DOROSHOW, M.D., PH.D. bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" — a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.

ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI
NEW YORK, NY

Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).

Industry payments received (2024) — CMS Open Payments transparency data

The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for DEBORAH DOROSHOW, M.D., PH.D.. Source: openpaymentsdata.cms.gov.

Total received

$5.2K

Largest payer

Takeda Pharmaceuticals U.S.A., Inc.

Most common payment type

Food and Beverage

Industry payments are not necessarily indicators of bias — they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.

License & disciplinary context — New York NYSBPMC 2023 annual report

Aggregate state board data only — NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~100K New York medical licensees in 2023 — they are NOT specific to DEBORAH DOROSHOW, M.D., PH.D.. To verify DEBORAH DOROSHOW, M.D., PH.D.'s current license status, search the NYSBPMC public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.

312
Total board actions, New York 2023
Across 302 cases
3.12
Actions per 1,000 licensees
New York statewide rate
probation
Most common action type
89 cases

NYSBPMC publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the New York disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.

Brand vs generic prescribing mix · Above average

DEBORAH DOROSHOW, M.D., PH.D. — brand share 26.0%
Specialty average (est.)

26% brand-name claims vs 74% generic, on 208 2023 Medicare Part D claims.

The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2023.

208
Total Claims
$383K
Total Drug Cost
36
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
221
Total Day Supply
5,037
Brand vs Generic
26% brand / 74% generic
Brand Drug Cost
$380K
Generic Drug Cost
$3K

Patient Demographics

Average Patient Age
74.0 years
Avg HCC Risk Score
3.54
Gender Split
69% female / 31% male

Top Prescribed Drugs (Medicare Part D)

Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.

Drug Claims
Ondansetron Odt
Ondansetron
18
Olanzapine
16
Folic Acid
15
Triamcinolone Acetonide
14
Tagrisso
Osimertinib Mesylate
13
Dexamethasone
12
Albuterol Sulfate Hfa
Albuterol Sulfate
11

* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.

Hematology & Oncology Physician Overview

How DEBORAH DOROSHOW, M.D., PH.D. fits within the Hematology & Oncology Physician landscape nationally.

11,215
Hematology & Oncology Physician Providers in US
54
States with Hematology & Oncology Physician
847
Avg Claims per Provider

DEBORAH DOROSHOW, M.D., PH.D.'s 208 claims are below the specialty average of 847.

Nearby Hematology & Oncology Physician Providers in New York

Other clinicians with the same primary specialty enrolled in New York, drawn from the same CMS NPPES roster as DOROSHOW.

Compare Hematology & Oncology Physician nationally: see state-by-state distribution →

Frequently Asked Questions

What is DEBORAH DOROSHOW, M.D., PH.D.'s specialty?
DEBORAH DOROSHOW, M.D., PH.D. specializes in Hematology & Oncology Physician and practices in NEW YORK, New York. Credentials: M.D., PH.D..
How much does DEBORAH DOROSHOW, M.D., PH.D. prescribe under Medicare Part D?
In 2023, DEBORAH DOROSHOW, M.D., PH.D. wrote 208 Medicare Part D claims totaling $383K in drug costs for 36 beneficiaries.
Where is DEBORAH DOROSHOW, M.D., PH.D. located?
DEBORAH DOROSHOW, M.D., PH.D. is located at 10 E 102ND ST, NEW YORK, NY, 10029. Phone: (212) 241-6756.
What is DEBORAH DOROSHOW, M.D., PH.D.'s NPI number?
DEBORAH DOROSHOW, M.D., PH.D.'s National Provider Identifier (NPI) is 1558706069, issued on 05/10/2013.
Does DEBORAH DOROSHOW, M.D., PH.D. prescribe more brand-name or generic drugs?
DEBORAH DOROSHOW, M.D., PH.D.'s prescribing is 26% brand-name and 74% generic drugs by claim count, with $380K in brand drug costs.
How many Hematology & Oncology Physician providers are there in the US?
There are 11,215 Hematology & Oncology Physician providers across 54 states in the US. The average Hematology & Oncology Physician provider writes 847 Medicare Part D claims per year.
What drugs does DEBORAH DOROSHOW, M.D., PH.D. prescribe most often?
Based on 2023 Medicare Part D data, DEBORAH DOROSHOW, M.D., PH.D.'s most frequently prescribed drugs include Ondansetron Odt, Olanzapine, Folic Acid. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does DEBORAH DOROSHOW, M.D., PH.D. accept Medicare?
DEBORAH DOROSHOW, M.D., PH.D. appears in CMS Medicare data with 208 Part D claims and 36 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify DEBORAH DOROSHOW, M.D., PH.D.'s credentials?
DEBORAH DOROSHOW, M.D., PH.D.'s NPI is 1558706069 with credentials M.D., PH.D.. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology